Apnicaf 20mg Oral Solution 1.5ml

Apnicaf 20mg Oral Solution 1.5ml

APNICAF 20MG ORAL SOLUTION contains Caffeine which belongs to the group of medicines called CNS stimulants. It is used to treat primary apnea (episodes of interrupted breathing) in premature babies. Primary apnea in premature babies happens due to immature development of baby’s breathing centers.

APNICAF 20MG ORAL SOLUTION has been shown to reduce the number of episodes of interrupted breathing in premature newborns babies. It can also be used to treat and prevent bronchopulmonary dysplasia (airway damage) among premature babies.

Before APNICAF 20MG ORAL SOLUTION is administered, inform your doctor if you child has any liver, kidney or heart problems. You must also inform your doctor if your child suffers from seizure disorders, slow weight gain or frequent regurgitation (spitting up of milk or food) as a precaution.

If you are the mother of the premature infant who receives the treatment, you must not drink coffee or take foods which has high caffeine content. This is because the caffeine taken by the breastfeeding mother may pass through the breast milk to the nursing premature infant who is already receiving caffeine therapy and may lead to an overdosage. The most common side effect of APNICAF 20MG ORAL SOLUTION is fast or irregular heart rate. Consult your doctor if it worsens.